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Abstract
Background: The complex mechanism responsible for tinnitus, a symptom highly prevalent in elderly patients,
could involve an impaired control of the microcirculation of the inner ear, particularly in patients with poor blood
pressure control and impaired left ventricular (LV) function.
Methods: In order to define the relationship between the presence of tinnitus and the severity and clinical
prognosis of mild-to-moderate chronic heart failure (CHF) in a large population of elderly patients (N = 958), a
cross-sectional study was conducted with a long-term extension of the clinical follow-up. Blood pressure,
echocardiographic parameters, brain natriuretic peptide (BNP), hospitalization, and mortality for CHF were
measured. Multivariate logistic regression analysis was used to assess the association between the presence of
tinnitus and some of the prognostic determinants of heart failure.
Results: The presence of tinnitus was ascertained in 233 patients (24.3%; mean age 74.9 ± 6 years) and was
associated with reduced systolic and diastolic blood pressure (123.1 ± 16/67.8 ± 9 vs 125.9 ± 15/69.7 ± 9; P = .027/P
= .006), reduced LV ejection fraction (LVEF%; 43.6 ± 15 vs 47.9 ± 14%, P = .001), and increased BNP plasma levels
(413.1 ± 480 vs 286.2 ± 357, P = .013) in comparison to patients without symptoms. The distribution of CHF
functional class was shifted toward a greater severity of the disease in patients with tinnitus. Combined one-year
mortality and hospitalization for CHF (events/year) was 1.43 ± 0.2 in patients with tinnitus and 0.83 ± 0.1 in patients
without tinnitus, with an adjusted hazard ratio (HR) of 0.61 (95% confidence interval (CI): 0.37 to 0.93, P <.002).
Conclusions: Our preliminary data indirectly support the hypothesis that tinnitus is associated with a worse CHF
control in elderly patients and can have some important clinical implications for the early identification of patients
who deserve a more aggressive management of CHF.
Background
Tinnitus is the perception of a sound that cannot be
attributed to an external source. It is a nonspecific
symptom generally referable to a largely unknown dys-
function of the hearing system. A comprehensive defini-
tion has been proposed [1] to differentiate normal ear
noises from pathological tinnitus defined as a head
noise lasting at least five minutes and that occurs more
than once per week. A distinction can also be made
between subjective and objective tinnitus [2]. The for-
mer is more common and refers to an individual sound
that is perceived only by the patient. From the epide-
miological point of view, tinnitus affects a remarkable
number of adults and is frequently associated with a
hearing loss of various degrees as expression of a
cochlear disorder [3,4]. In the United Kingdom approxi-
mately 4.7 million of patients are affected by tinnitus [5]
and about 5% of them have experienced a severe and
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any medium, provided the original work is properly cited.persistent disorder that affects their quality of life [6].
The American Tinnitus Association has reported a pre-
valence of about 19% (37 to 40 million), which increases
with age and the degree of hearing impairment [4]. The
prevalence of tinnitus has been reported to be higher in
m e nt h a ni nw o m e n ,a n dt h i sd i f f e r e n c em i g h tb e
related to higher hearing thresholds in the male popula-
tion [3,4]. Interestingly, only 1% of patients under 45
years of age experience tinnitus, while the prevalence is
about 12% in those 60 to 69 years of age and 25 to 30%
in those who are > 70. Similar data recently have also
been reported in a large cross-sectional study carried
out with participants in the 1999 to 2004 US National
Health and Nutrition Examination Surveys [7]. Several
anatomical regions could contribute to the generation of
tinnitus [8], even if a causative relationship between
neurophysiological functions and tinnitus generation has
not yet been demonstrated [9]. Moreover, several patho-
physiological hypotheses have recently been proposed to
explain the genesis of different kinds of tinnitus: from
genetic to iatrogenic, from neurological to vascular [10].
However, a final and unique explanation is not actually
available. In this complex scenario, tinnitus associated
clinical conditions, such as vascular diseases, middle ear
diseases, diabetes, hypertension, autoimmune disorders,
and degenerative neural disorders with or without con-
comitant hearing loss [9-12], a functional component
leading to an impaired regulation of the peripheral vas-
cular tone can be demonstrated. For that reason, at least
partly, tinnitus could be the expression of a circulatory
impairment of the microcirculation of the inner ear
resulting from a detrimental feedback loop between the
control of systemic blood pressure and the reflex activa-
tion of the neurohumoral system (for example, sympa-
thetic nervous system and renin-angiotensin-aldosterone
system (RAAS)) [13,14]. Accordingly, any clinical condi-
tion leading to a reduction in systemic and/or regional
blood flow at the ear level can trigger the onset of tinni-
tus or promote its exacerbation in patients already
affected by this disorder.
Chronic heart failure (CHF) could be an ideal biologi-
cal model to test the vascular disregulatory hypothesis
of tinnitus since it is often associated with a reduced
cardiac output, as well as with a reflex activation of
vasoconstrictive systems, including the sympathetic ner-
vous system and RAAS [15]. The prevalence of CHF is
significantly increased in the elderly population [16],
who also have a higher rate of tinnitus [3,4] and afford
researchers with a reliable clinical setting to investigate
the circulatory origin of hearing disorders.
The main objective of the present study is two-fold:
To assess the prevalence of tinnitus in a large popula-
tion of elderly patients with CHF, and to define the
relationship between the presence of such an ear disor-
der and the severity and clinical prognosis of CHF
Methods
This is a cross-sectional study with a long-term exten-
sion of the clinical follow-up. The researchers evaluated
958 consecutive elderly patients (age > 65 years) with a
diagnosis of CHF (New York Heart Association (NYHA)
functional class I to III) who were attending the Outpa-
tients Clinic for Congestive Heart Failure of the Depart-
ment of Medicine at the University of Bologna. CHF
was diagnosed by the same two well-trained physicians
according to the standard criteria proposed by the
European Society of Cardiology [16].
Exclusion criteria were: stage 3 to 5 chronic renal fail-
ure, hypoproteinemia, recent increase in diuretic dosage
(less than 30 days) or diuretic dosage change during the
follow-up, concomitant use of other ototoxic drugs (that
is, aminoglycosidics), continuous use of fully dosed
non-steroideal antinflammatory drugs (NSAIDs). NSAID
use was considered as acceptable if limited to less than
one dose per week and with a limited dosage (that is,
paracetamol 1,000 mg, acetilsalycilate 500 mg).
All patients underwent physical examinations and
blood pressure measurements. Blood pressure was mea-
sured in the supine position after five minutes of rest,
with a mercury sphygmomanometer. The systolic and
diastolic blood pressure values were read to the nearest
2 mmHg. Three measurements were taken at two-min-
ute intervals, and the average value was used to define
clinical systolic and diastolic blood pressure. The pre-
sence of tinnitus was assessed by a standardized ques-
tionnaire (see Additional file 1) that allowed the
categorical definition of the presence or absence of the
disease based on few and specific items. The question-
naire has been largely validated in clinical practice and
its sensitivity and specificity is over 80% [17-19]. All
patients underwent a clinical otological and audiological
examination to rule out identifiable causes of tinnitus.
During the initial visit, demographic and anthropometric
parameters of each patient were recorded, as well as the
family history of cardiovascular disease and lifestyle
information. Information was also collected about the
distribution of all major cardiovascular risk factors and
pharmacological treatments. The severity of CHF was
defined according to NYHA functional classification,
while a determination of plasma levels of brain natriure-
tic peptide (BNP) and a comprehensive echocardio-
graphic evaluation, including left ventricular ejection
fraction (LVEF) and end-systolic and end-diastolic
volumes, were individually carried out to define more
accurately the characteristics of the disease as well as
the level of hemodynamic deterioration. To further
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actively followed-up on an intention-to-treat basis for a
cumulative period of 12 months after enrolment in the
s t u d yt oa s s e s sm o r t a l i t ya n dt h er a t eo fh o s p i t a l i z a t i o n
for CHF. The results were then compared between
patients with and without hearing disorders.
The study was fully conducted in accordance with the
Declaration of Helsinki. The study protocol was
approved by the Ethical Committee of the University of
Bologna and informed consent was obtained from all
patients before the inclusion in the study.
Statistical analysis
Results are expressed as mean ± standard deviation
(SD). Normality of the distribution of the data was
examined with the Kolmogorov-Smirnov test. Continu-
ous variables are expressed as mean ± SD or median
with interquartile range as appropriate, and categorical
variables are expressed as a percentage. Data that were
not normally distributed were logarithmically trans-
formed before analysis. Comparisons among groups
were made by t-test for continuous variable and chi-
square tests (c
2) for categorical variables. Associations
between variables were tested using Pearson’s coefficient
and correlation in the overall population of patients, as
well as in patients with and without tinnitus. Multivari-
ate logistic regression analysis was used to assess the
association between the presence of tinnitus and some
of the prognostic determinants of heart failure, including
LVEF%, levels of BNP, age, and gender and presence of
presbyacusis (bilateral loss > 30 decibels between 4,000
and 8,000 Hz). The statistical analysis was carried out
by using a SPSS statistical package (version 9.6.2 for
Windows; SPSS Inc., Chicago, IL, USA).
Results and discussion
Among the 958 patients, 530 (55.3%) were male and 428
(44.7%) female (mean age 73.9 ± 11). The presence of
tinnitus was ascertained in 233 patients (24.3%; female/
male: 111/122, mean age 74.9 ± 6 years), while 725
patients (75.7%; female/male: 317/408, mean age 73.6 ±
7 years) were symptom-free. The baseline clinical, echo-
cardiographic, and neurohumoral characteristics of the
population are reported in Table 1. There was no obser-
vation of any difference in the age and gender distribu-
tion between patients with and without tinnitus. Systolic
and diastolic blood pressure values were significantly
lower in patients with tinnitus as opposed to those with-
out it, while the prevalence of systolic blood pressure
values < 100 mmHg was 9.9% in patients with tinnitus
and 5.1% in control patients. In terms of LV function,
patients affected by tinnitus showed significantly lower
values of EF% associated with higher plasma levels of
BNP. As expected, in the overall population a linear
correlation was found between LVEF% and the plasma
levels of log-BNP (R = 0.413, P <.0001). The correlations
between EF% and plasma BNP levels in patients with
and without tinnitus are reported in Figure 1. A strong
linear inverse relationship was observed in both popula-
tions of patients where it achieved statistical significance
(patients with tinnitus: R = 0.4193, P <.005; patients
without tinnitus: R = 0.4060, P <.001). A combination of
reduced LVEF (< 45%) and BNP levels above the normal
value (100 pg/mL) was observed in 31.3% (73/233) of
the patients with tinnitus and in only 18.3% (133/725)
of those free from symptoms. The difference achieves
statistical significance (P <.003). This suggests a greater
degree of systolic dysfunction in patients with tinnitus.
The distribution of NYHA functional class in the
population of patients with CHF and tinnitus showed a
rightward shift (Figure 2) with a greater proportion of
patients in NYHA classes II and III when compared
with the population of patients without tinnitus. A sepa-
rate analysis was carried out in patients with a more
severe impairment in LVEF (< 40%), and it confirmed
the greater proportion of patients in NYHA classes II
and III among those affected by tinnitus (Figure 2),
thereby excluding the possibility that differences in LV
function are primarily responsible for the observed dis-
tribution of NYHA functional class in patients with and
Table 1 Baseline clinical, echocardiographical, and
neurohumoral characteristics of the population
Presence of tinnitus P-value
Yes No
Male 122 (52.3%) 408 (52.6%) NS
Female 111 (47.7%) 317 (47.4%) NS
Ethiology of CHF (%)
Hypertension 30.0 31.7 NS
Ischemic 41 40 NS
CMP 23.3 24.3 NS
Valve disease 3.7 3 NS
Other 2.0 1 NS
Age (years) 74.9 ± 6 73.6 ± 7 n.s.
BMI (kg/m²) 26.6 ± 4 27 ± 4 n.s
Lying SBP (mmHg) 123.1 ± 16 125.9 ± 15 .027*
Standing SBP (mmHg) 118.3 ± 18 121.3 ± 17 .024*
Lying DBP (mmHg) 67.8 ± 9 69.7 ± 9 .006*
Standing DBP (mmHg) 66.7 ± 9 68.8 ± 9 .003*
BNP (pg/ml) 413.1 ± 480 286.2 ± 357 .013*
EF (%) 43.6 ± 15 47.9 ± 14 .001*
%E F≤ 45% 50.6 ± 12 39.9 ± 12 .001*
LV TDV (mL) 144 ± 23 118 ± 24 .001*
LV TSV (mL) 53 ± 10 46 ± 9 NS
Abbreviations: BMI, body mass index; BNP, brain natriuretic peptide; CHF,
congestive heart failure; CMP, cardiomiopathy; DBP, diastolic blood pressure;
EF, ejection fraction; LV, left ventricular; NS, not significant; SBP, systolic blood
pressure; TDV, total distribution volume.
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Page 3 of 8Figure 1 Correlation between ejection fraction (EF%) and brain natriuretic peptide (BNP) in the group with tinnitus and those without
tinnitus.
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Figure 2 Distribution of New York Heart Association (NYHA) functional class among all patients (P for trend <.001) (A) and among the
subgroup with impaired left ventricular ejection fraction ((LVEF%) < 40%; P for trend <.05). (B)
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Page 4 of 8without tinnitus. Multivariate logistic regression analysis
(Table 2) showed that the presence of tinnitus was
mainly associated with reduced LVEF% (< 45%). Addi-
tional risk factors were NYHA > II to III class and
higher levels of BNP, while age, gender and presence of
presbyacusis were not directly related with tinnitus.
The percentages of distribution of concomitant drug
treatment in the two populations of patients are
reported in Table 3. Patients with tinnitus showed a
greater use of angiotensin receptor blockers and diure-
tics, which probably reflects the larger proportion of
patients with more severe NYHA functional class and
might explain the lower BP values. Repeating the survi-
val analysis by angiotensin receptor blockers use, the
trend was not significantly different between users and
non-users. Interestingly, tinnitus was also associated
with a greater use of NSAIDs, which could partially
explain the differences in terms of clinical profile and
LV function between patients with and without tinnitus,
even if those drugs were used on demand and at low
dosage. On the other side, repeating the survival analysis
by NSAID use, the trend was not significantly different
between users and non-users.
In terms of clinical prognosis, the combined rate of
death plus hospitalization for CHF (events/year) during
the 12 months after the enrolment in the study was 1.43
± 0.2 in patients with tinnitus and 0.83 ± 0.1 in patients
without tinnitus, with a Hazard Ratio of 0.61 (95% CI:
0.37 to 0.93). The difference achieved statistical signifi-
cance (P <.002) and persisted after adjustment for major
confounding prognostic factors (age, gender, EF, BNP
levels, and drug treatment; Figure 3).
Tinnitus affects a considerable number of adult
patients, and its prevalence increases with age, with a
large proportion of the elderly population affected by
this common hearing disorder. The results of the pre-
sent study suggest that in elderly patients with CHF, the
presence of tinnitus is associated with a higher preva-
lence of LV dysfunction. Moreover, a large proportion
of patients with tinnitus showed the combination of low
levels of EF with elevated plasma levels of BNP as a
measure of systolic dysfunction and cardiac overload.
The one-year mortality and hospitalization for CHF was
significantly increased in patients with tinnitus as an
expression of a greater degree of clinical instability of
the disease. From a speculative point of view, this sug-
gests the possibility that the onset of tinnitus or the
worsening in its severity may be considered as an indir-
ect symptom of poor hemodynamic stability in elderly
patients with CHF. Of course, the causal relationship
between CHF and tinnitus onset or worsening has to be
further investigated with more appropriate studies. In
fact, tinnitus could have origins other than or concomi-
tant to circulatory disorders, including localized cochlear
disorders [20], hormonal causes [21], dysregulation of
the limbic system [22] or a complex interplayamong
sensory, cognitive and affective systems [23]. However,
the mechanism responsible for the increased rate or the
exacerbations of tinnitus in elderly patients with CHF
could also be identified in the combination between the
hemodynamic failure typical of CHF and the lack of any
effective autoregulatory control of inner ear circulation
leading to a sudden or persistent systemic blood pres-
sure decrease. The possibility that the onset of tinnitus
is related to a systemic hypotensive response involving
directly or indirectly the microcirculation of the inner
ear has already been investigated in patients with and
without hypertension [24-26]. An increase in the preva-
lence of tinnitus has been found in patients with hyper-
tension aggressively treated with blood pressure
lowering drugs, while an interesting relationship has
been described between the time-course of individual
hypotensive episodes and the onset of hearing symptoms
[24]. In the present study, blood pressure values were
lower in the advanced NYHA classes (NYHA I to II
127.5 ± 13/70.2 ± 7 vs NYHA III 119.4 ± 11/65.1 ± 7;
P <.0001) as a consequence of the greater impairment of
Table 2 Multivariate analysis of clinical correlates with
the presence of tinnitus in the patients population
Variable Odds ratio P-value
Age > 70 years 1.02 0.14
Gender female 0.97 0.23
LVEF % < 45 1.28 0.001
BNP > 200 mg/dL 1.09 0.05
Presbyacusis yes* 1.02 0.27
*Bilateral loss of 30 decibels between 4,000 and 8,000 Hz.
Table 3 Distribution of concomitant drug treatment
Therapy Yes No Tinnitus
Yes
Tinnitus
No
P-
value
ACE-inhibitors 53.24 46.76 51.50 53.79 NS
ARBs 52.92 47.08 63.95 49.38 .001
Antiplatelets 86.22 13.78 84.55 86.76 NS
NSAIDs 22.38 77.62 37.07 17.68 .001
Ca antagonist 19.83 80.17 16.81 18.89 NS
Warfarin 19.24 80.76 20.35 56.55 NS
Diuretics 58.77 41.23 65.67 53.9 .014
Alfa-blockers 5.45 94.5 5.60 4.66 NS
Beta-blockers 42.48 57.52 75.06 78.2 NS
Statins 5.38 94.62 7.82 4.63 NS
Nitroderivates 25.45 74.55 22.84 26.28 NS
Antialdosterone
drugs
14.03 85.97 16.81 13.14 NS
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor
blocker; Ca, calcium; NS, not significant; NSAIDs, nonsteroidal anti-
inflammatory drugs.
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in the onset of tinnitus in the different subsets of
patients with CHF. The same explanation applies to the
correlations between the prevalence of tinnitus and the
levels of LVEF% or BNP, suggesting a close relationship
between the systemic hemodynamic profile and the
response of the inner ear circulation and/or the ear sen-
sorineural pathway. This would reasonably exclude the
possibility of an exclusive role of a primary sensori-
neural derangement in patients with CHF, since if this
was the case the prevalence of tinnitus would be largely
independent from the extent of LV dysfunction. In fact,
the decrease in cardiac output and the associated vaso-
constrictive response observed in patients with heart
failure can significantly reduce the blood supply to the
inner ear. This peripheral hemodynamic response can-
not be compensated by a modification of arterial tone
because of the peculiar characteristics of the inner ear
circulation [11,12] and would result in the development
of a local condition of hypoperfusion/ischemia with the
activation or enhancement of the sensorineural mechan-
isms that produce tinnitus. The degree of the ischemic
response would be proportional to the decrease in blood
supply, as well as to the extent of functional heart fail-
ure; thus supporting the relationship observed between
severity of CHF and percentage of patients affected by
tinnitus. The close relationship between impaired LV
function and presence of tinnitus is also supported by
the observation of a worst clinical prognosis in the
population who complain about the symptoms. As an
alternative hypothesis, the onset of tinnitus can be
related to the high prevalence of depressive symptoms
in patients with CHF. We estimated the rate of depres-
sion in our population by DSM-III criteria and the pro-
portion of affected patients was comparable between
those with and without tinnitus (47% vs. 44%; P =N S ) .
This reasonably excludes a primary role for depression
in the onset or exacerbation of tinnitus, while the
importance of such a disease as responsible for these
symptoms in the overall population cannot be ruled out.
On the other side, the lack of association between tinni-
tus and auditory thresholds in our patients could be
related to the extreme variability in the entity of the
hemodynamic derangement that affect the patients with
heart failure and that could promote the onset of tinni-
t u so na ni s c h e m i ca n dr e v e r s i b l eb a s i sw i t h o u ta n y
major evidence of a concomitant and persistent hearing
impairment. Actually, tinnitus is a spontaneous symp-
tom that is immediately perceived without any external
stimulation, whereas the perception of hearing impair-
ment needs an external acoustic trigger. This could have
increased the sensitivity of our patients toward tinnitus
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Figure 3 Twelve-month event-free survival in congestive heart failure (CHF) patients with or without tinnitus.
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speculate about the possibility that two separate
mechanisms of action might contribute to the same
symptom, namely one functional (hemodynamic
derangement) and the other more structural (hearing
disturbance).
The clinical relevance of tinnitus is primarily depen-
d e n to nt h ed e g r e eo fL Vd y s f u n c t i o n –the major
responsibility for signs and symptoms of heart failure.
However, the results of the logistic regression analysis
support an independent role for the presence of tinnitus
after adjustment for the major confounding risk factors,
including any measure of LV dysfunction. The present
study probably provides the first evidence of the possibi-
lity that the hearing system can be involved in the over-
all assessment of the clinical outcome of patients with
CHF in addition to typical prognostic indicators (for
example, LVEF%, plasma levels of BNP).
The use of tinnitus as a measure of severity and stabi-
lity of heart failure in the elderly population could be
complementary to the use of hemodynamic or biochem-
ical markers, since it is easy to assess, does not require
any blood sample or instrumental evaluation, and can
be perceived by patients when other signs or symptoms
of the disease have not yet developed. In particular, the
observation of an increase in the relative risk of major
cardiovascular events in patients with CHF and tinnitus
might support the possibility that the onset of tinnitus
can be considered as a useful indicator of a decline in
cardiac performance well before the development of the
typical manifestations of heart failure. This is supported
by the higher proportion of patients treated with
NSAIDs among those who complain of tinnitus (see
Table 2). Indeed, the use of NSAIDs is one of the most
common causes of hospitalization in patients with
chronic CHF [27]. This is because the use of such drugs
can impair renal function and promote fluid overload
with a resulting decline in LV systolic function, which
leads to the onset of tinnitus, as well as to symptoms of
heart failure.
As expected, the study has several limitations accord-
ing to its design and the nature of the observation. First,
the study was carried out exclusively in the elderly
population and it is unknown if the presence of tinnitus
has the same relevance in younger patients with CHF.
Nevertheless, since the relationship between tinnitus
and CHF appears to be mainly related to the extent of
decline in LV function, we should expect a unique cau-
sative mechanism regardless of the age of the patients.
Second, the enrolment of patients was based on the use
of an individual questionnaire without any additional
and confirmatory evaluation of the presence of tinnitus.
According to the universally accepted definition, tinnitus
is a perceived sound that cannot be attributed to an
external source. This implies only a categorical estimate
based on its presence or absence. In addition, the ques-
tionnaire provides a semiquantitative estimate of the
presence of tinnitus and has been validated in a large
population of patients with a different set of comorbid-
ities where it has been demonstrated to be accurate and
reproducible for the diagnosis of tinnitus [17-19]. Third,
no information was provided about the relationship
between changes in LV function and the onset and per-
sistence of tinnitus over a period of follow-up. However,
the study protocol was finalized to assess if the presence
of tinnitus at any time in the clinical history of the
patients might affect the long-term prognosis. The dis-
criminatory power of this approach could have been
biased by those patients whose tinnitus had developed
after the baseline evaluation, even if the difference
observed in terms of mortality and morbidity between
the two groups of patients did not support such inter-
pretation. Finally, the study does not provide any infor-
mation about the meaning of tinnitus in patients with
cardiovascular diseases other than CHF. It is unknown if
the presence of tinnitus is the nonspecific consequence
of a reduction in regional blood flow at the level of the
inner ear or if it necessarily implies a concomitant acti-
vation of the sympathetic nervous system and RAAS as
occurs in most patients with CHF. The evidence pro-
vided by the studies carried out in patients with hypo-
tension supports a generalized hemodynamic
mechanism, but the importance of the involvement of
the neurohumoral system cannot be ruled out and
deserves further investigations.
In our patients, microcircular dysfunction of the inner
ear may generate tinnitus without having an influence
on auditory thresholds
Conclusion
To date, this is the first large, cross-sectional, clinical
study supporting an association between tinnitus and
CHF control in elderly patients. Data suggest that the
onset of tinnitus might be affected by the degree of
decline in LV function and is probably the consequence
of an insufficient autoregulatory mechanism at the level
of the circulation of the inner ear. These data can have
some important clinical implications including the pos-
sibility that the onset and/or worsening of tinnitus can
antedate the destabilization of CHF. This would allow
for the early identification of patients who deserve a
more aggressive management of heart failure or an
adjustment of drug treatment, including a cautious
administration of NSAIDs. If confirmed by larger pro-
spective studies, this evidence would indirectly contri-
bute to improve the quality of life of patients with CHF
and might reduce the rate of hospitalization, as well as
the huge economic burden of the management of CHF.
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Additional files 1: Questionnaire sent to asses the presence of
tinnitus.
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